Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

Marc Shapiro, MD

216.444.6833

Marc Shapiro, MD
Department: Hematology and Oncology
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
DeskDesk:216.445.2067
WorkFax:216.444.9464
Marc Shapiro, MD
Department: Genomic Medicine Institute
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
DeskDesk:216.445.2067
WorkFax:216.444.9464
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Marc Shapiro, MD, was born and raised in Cleveland, Ohio. He attended medical school at the Medical College of Ohio in Toledo. He completed his internal medicine training at Emory University in Atlanta, Ga., and earned his board certification in internal medicine in 2001. Dr. Shapiro completed his specialty training in medical oncology and hematology at Fox Chase Cancer Center and Temple University in Philadelphia, Pa. He is now an Associate Staff member in the Department of Solid Tumor Oncology at Cleveland Clinic.

Dr. Shapiro's clinical interests include the treatment of lung, breast, gastrointestinal and occult cancers.

Education & Fellowships

Fellowship - Fox Chase Cancer Center
Medical Oncology/Hematology
Philadelphia, PA USA
2007
Residency - Emory University Hospital
Internal Medicine
Decatur, GA USA
2004
Internship - Emory University Hospital
Internal Medicine
Decatur, GA USA
2002
Medical School - Medical College of Ohio at Toledo
Toledo, OH USA
2001
Undergraduate - University of Pennsylvania
Philadelphia, PA USA
1997

Certifications

  • Internal Medicine
  • Internal Medicine- Medical Oncology
  • Internal Medicine- Hematology

Specialty Interests

Solid tumor oncology, cancer of unknown primary, cancer, colorectal cancer, esophageal cancer, extrahepatic bile duct cancer, gallbladder cancer

Memberships

  • American Society of Clinical Oncology
  • American College of Physicians

Treatment & Services

  • Chemotherapy
  • Clinical Trials
  • Medical Oncology
  • Screening and Testing

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/24/2014, Dr. Shapiro has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English